Prevent Cancer Foundation's 2025 Early Detection Survey showed that only about half of U.S. adults 21 years and older said ...

INmune Bio Inc. (NASDAQ: INMB) a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system has partnered with the Cell and Gene Therapy Catapult (CGT ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Teddi Mellencamp, who is battling stage four melanoma, revealed that her doctors have given her 50/50 odds of beating her ...

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

In the study, 320 men between ages 45–75 saw a significant reduction in nocturia, inflammation, and urinary urgency over a 24 ...

“Science is rarely a straight line, and while ... cancer fail Along with prostate cancer disappointment, Merck also reported a surprising failed trial in non-small cell lung cancer (NSCLC ...

Dalgliesh's spin-off company Onyvax currently has a prostate cancer vaccine, Onyvax-P, in Phase III trials. Onyvax-P comprises a series of cell lines representing different stages of prostate ...

It's no secret that diet can have a big impact on our health, but it could also play a part in the development of cancer.